CStone Pharmaceuticals proposed to list an initial public offering on the Hong Kong stock exchange. The company has an ongoing late-stage study of CS1001 in China for non-small cell lung cancer, and intends to launch Phase III trials for stage 4 NSCLC by the end of this year and trials for hepatocellular carcinoma and gastric cancer in the first half of next year.
Researchers from Rice University used CRISPR-Cas9 technology to modify a baculovirus, based on a virus that affects moths, because it can carry up to eight times more DNA pairs than other viral delivery methods. In the study, baculovirus vectors are loaded with the immune system protein C3, which allows the researchers to inactivate and reactivate the virus using a magnetic field to deliver treatments precisely where they are needed.
A quarterly report published by the UK Department for Transport indicated that 525 million liters of renewable fuel were supplied between April 15 and Sept. 17, of which 172 million liters met the UK's sustainability requirements.
The latest ad campaign from the American Lung Association resembles a true crime show and is aimed at women. The ads will run during true crime shows and podcasts.
Tobacco-related health care costs are more than $7 billion in Minnesota, according to an ad campaign by ClearWay Minnesota and agency Haberman. The campaign notes that teen smoking rates are increasing, mainly because of e-cigarettes.
A round of financing led by Australian implantable hearing solutions firm Cochlear has brought in $17.1 million for Belgium-based Nyxoah, which makes a hypoglossal nerve stimulation therapy to treat obstructive sleep apnea. Nyxoah will use the money for post-CE mark market-development programs in Europe, as well as to seek investigational device exemption from the FDA.
A round of financing has brought in $17 million for Aegea Medical, which makes the Adaptive Vapor Ablation technology. The proceeds will be used to advance a prospective, multicenter study and to release its technology for minimally invasive treatment of heavy menstrual bleeding next year.
NuVasive saw 10.2% year-over-year revenue growth in the third quarter, topping the orthopedic device companies that recently reported earnings. Stryker followed with 7.9% organic, constant currency revenue growth, while Johnson & Johnson saw near flat orthopedic device sales.
A PwC report predicts the health care industry will overtake other industries in terms of research and development spending by 2020. The health care industry, which currently ranks second in R&D spending after the computing and electronics industry, has 23 companies listed in the report as "high leverage innovators" for 2017, including Medtronic, Hologic and Fresenius Medical Care.
Research Reports predicts the worldwide market for surgical navigation systems will see a compound annual growth rate of 4.4% through 2023, with the US market hitting $780 million. Key market players include Medtronic, Stryker, Johnson & Johnson, Zimmer Biomet, Brainlab and XION.